UAB and UMass researchers have uncovered a new mechanistic understanding of potential treatment for genetic disorders.
Improved production of stem cells is vital if they are to achieve their promise for medical research and disease treatments like transplantation, creating patient-specific cell-replacement therapies to treat neurological diseases, heart ailments, blood diseases and diabetes.
Greater efficiency is a must for future clinical use of these cells in regenerative medicine, drug screening and disease study.
David M. Bedwell, Ph.D., professor in the Department of Microbiology and associate director of the Gregory Fleming James Cystic Fibrosis Center, has been named the interim chair of the UAB Department of Biochemistry and Molecular Genetics.
UAB-led research shows how methylating an RNA binding protein leads to alternative RNA splicing. Mutant enzymes are often found in blood cancers.
Researchers have received funding to seek and validate biomarkers for the progressive, inherited disease Friedreich’s ataxia, a life-shortening degenerative neuromuscular disorder.
UAB researchers discover a new protein interaction from the 1918 flu strain that may help influenza circumvent the host immune response that would fight viral infection.
Louise T. Chow, Ph.D., professor in the Department of Biochemistry and Molecular Genetics, has been chosen as one of the Women of Consequence honorees for the 2015 International Women’s Day Awards Dinner.
Professor of Microbiology David Briles, Ph.D., and Professor of Optometry Lawrence DeLucas, O.D., Ph.D., will be inducted into the NIA, professional distinction accorded to academic inventors.
The new 1,600-square-foot Central Alabama High-Field Nuclear Magnetic Resonance Facility provides state-of-the-art sensitivity and resolution for biomedical research and drug discovery.